{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:11:48Z","timestamp":1790053908477,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006387","name":"Fondation Leenaards","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jinf.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:53:32Z","timestamp":1626875612000},"page":"354-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial"],"prefix":"10.1016","volume":"83","author":[{"given":"Matteo","family":"Mombelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hoschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Cavassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.jinf.2021.07.010_bib0001","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modeling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jinf.2021.07.010_bib0002","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/cid\/ciz638","article-title":"Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011\u20132015","volume":"70","author":"Collins","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.010_bib0003","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-Year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2021.07.010_bib0004","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/ajt.16383","article-title":"Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study","volume":"21","author":"Mombelli","year":"2021","journal-title":"Am J Transpl"},{"issue":"20","key":"10.1016\/j.jinf.2021.07.010_bib0005","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jinf.2021.07.010_bib0006","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archinte.161.3.441","article-title":"Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome","volume":"161","author":"Lin","year":"2001","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.jinf.2021.07.010_bib0007","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/infdis\/jis487","article-title":"et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis","volume":"206","author":"Beck","year":"2012","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2021.07.010_bib0008","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ijd.13235","article-title":"Imiquimod in dermatology: an overview","volume":"55","author":"Hanna","year":"2016","journal-title":"Int J Dermatol"},{"issue":"15","key":"10.1016\/j.jinf.2021.07.010_bib0009","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/dji207","article-title":"Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment","volume":"97","author":"Urosevic","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.010_bib0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/CVI.00816-13","article-title":"Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB\/c mice","volume":"21","author":"Zhang","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.010_bib0011","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/cid\/ciu582","article-title":"Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial","volume":"59","author":"Hung","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.010_bib0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(15)00354-0","article-title":"Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b\/3 trial","volume":"16","author":"Hung","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.010_bib0013","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1007391222905","article-title":"Molecular analysis of an outbreak of influenza in the United Kingdom","volume":"13","author":"Ellis","year":"1997","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jinf.2021.07.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab206","article-title":"Topical imiquimod does not provide an adjuvant effect when administered with inactivated influenza A\/H5N1 vaccine in healthy young adults","author":"El Sahly","year":"2021","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2021.07.010_bib0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jinf.2021.07.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136047","article-title":"TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women","volume":"5","author":"Azar","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jinf.2021.07.010_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAD.0b013e32831fb540","article-title":"A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression","volume":"23","author":"Oh","year":"2009","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.010_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2008.09.023","article-title":"Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study","volume":"54","author":"Birdwell","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"41","key":"10.1016\/j.jinf.2021.07.010_bib0019","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1016\/j.vaccine.2018.08.057","article-title":"Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: a randomized controlled trial","volume":"36","author":"Mombelli","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.010_bib0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/TP.0b013e31825f7f82","article-title":"Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients","volume":"94","author":"Orcurto","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.010_bib0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ki.2012.106","article-title":"Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination","volume":"82","author":"Mulley","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.010_bib0022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cid\/ciq019","article-title":"Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults","volume":"52","author":"Crum-Cianflone","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2021.07.010_bib0023","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/civ884","article-title":"Randomized controlled trial to compare immunogenicity of standard-dose intramuscular versus intradermal trivalent inactivated influenza vaccine in HIV-infected men who have sex with men in Bangkok, Thailand","volume":"62","author":"Garg","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.jinf.2021.07.010_bib0024","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/QAD.0b013e32833c6d5c","article-title":"Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals","volume":"24","author":"Tebas","year":"2010","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.010_bib0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1468-1293.2011.00987.x","article-title":"Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere","volume":"13","author":"Maruszak","year":"2012","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.010_bib0026","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cid\/ciq104","article-title":"Humoral response to the influenza A H1N1\/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients","volume":"52","author":"Manuel","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"52","key":"10.1016\/j.jinf.2021.07.010_bib0027","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1016\/j.vaccine.2009.10.033","article-title":"Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study","volume":"27","author":"Arnou","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jinf.2021.07.010_bib0028","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/590434","article-title":"Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial","volume":"198","author":"Holland","year":"2008","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.010_bib0029","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.healun.2011.01.705","article-title":"Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients","volume":"30","author":"Manuel","year":"2011","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.010_bib0030","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ajt.12149","article-title":"Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients","volume":"13","author":"Baluch","year":"2013","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.010_bib0031","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/21645515.2015.1076599","article-title":"Safety and immunogenicity of influenza vaccine among HIV-infected adults: conventional vaccine vs. intradermal vaccine","volume":"12","author":"Seo","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2021.07.010_bib0032","article-title":"A double-blind randomized phase 2 controlled trial of intradermal hepatitis B vaccination with a topical Toll-like receptor 7 agonist imiquimod, in patients on dialysis","author":"Hung","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"26","key":"10.1016\/j.jinf.2021.07.010_bib0033","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.vaccine.2010.04.029","article-title":"Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara)","volume":"28","author":"Roukens","year":"2010","journal-title":"Vaccine"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:33:39Z","timestamp":1759008819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321003534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0163445321003534"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.010","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}